Allergan, Inc. v. Lupin Ltd. et al
||Lupin Pharmaceuticals, Inc. and Lupin Ltd.
||December 30, 2011
||US District Court for the Eastern District of Texas
|Nature of Suit:
|Cause of Action:
|Jury Demanded By:
Access additional case information on PACER
Available Case Documents
The following documents for this case are available for you to view or download:
|August 21, 2013
MEMORANDUM OPINION and ORDER - The Court adopts the constructions set forth in this opinion for the disputed terms of the 338 and 982 patents. There are no disputed terms for the 215 patent. Within thirty (30) days of the issuance of this Memorandum Opinion and Order, the parties are hereby ORDERED, in good faith, to mediate this case with David Folsom, the mediator appointed in this case. Signed by Judge Rodney Gilstrap on 8/20/13. (ehs, )
Use the links below to access additional information about this case on the US Court's PACER system.
A subscription to PACER is required.
Access this case on the Texas Eastern District Court's Electronic Court Filings (ECF) System
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?